Prato Sesia, Italy

Alberto Massarotti


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alberto Massarotti: Innovator in Phosphatidylinositol 3-Kinase Inhibition

Introduction

Alberto Massarotti is a notable inventor based in Prato Sesia, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit phosphatidylinositol 3-kinases. His work has implications for treating various pathological conditions associated with kinase activity alterations.

Latest Patents

Massarotti holds a patent for "Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases." This patent describes compounds of Formula (I) that are capable of inhibiting kinase activity, specifically targeting phosphatidylinositol 3-kinases. The disclosure also highlights the potential use of these compounds in treating conditions linked to abnormal phosphatidylinositol 3-kinase activity.

Career Highlights

Throughout his career, Alberto Massarotti has worked with prestigious institutions, including the University of Turin and the University of Eastern Piedmont "Amedeo Avogadro." His research has focused on the biochemical pathways involving phosphatidylinositol 3-kinases, contributing to a deeper understanding of their role in various diseases.

Collaborations

Massarotti has collaborated with esteemed colleagues such as Giovanni Sorba and Gian Cesare Tron. These partnerships have enriched his research and expanded the impact of his findings in the scientific community.

Conclusion

Alberto Massarotti's innovative work in the field of phosphatidylinositol 3-kinase inhibition showcases his dedication to advancing medical science. His contributions are vital for developing new therapeutic strategies for diseases associated with kinase activity alterations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…